| Description |
xviii, 245 pages : illustrations (some color) ; 26 cm |
| Series |
Curbside consultation in gastroenterology |
|
Curbside consultation in gastroenterology.
|
| Contents |
Machine derived contents note: Contents -- Dedication -- Acknowledgments -- About the Editor -- Contributing Authors -- Preface -- Section I: Viral Hepatitis C -- Question 1: What Is the Likelihood That My Patient With Chronic Hepatitis C -- Will Develop Cirrhosis, Heaptocellular Carcinoma, and/or Hepatic -- Decompensation? -- Seela Ramesh, MD and Mitchell L. Shiffman, MD -- Question 2: How Should a Patient Who Tests Positive for Chronic Hepatitis C -- but Has Persistently Normal Serum Liver Amino-Transaminases -- Be Evaluated? -- Ramesh Ashwath, MD and Mitchell L. Shiffman, MD -- Question 3: Do All Patients With Chronic Hepatitis C Virus Require a Liver Biopsy? -- Ramesh Ashwath, MD and Mitchell L. Shiffman, MD -- Question 4. How Often Should I Measure HCV RNA While Treating a Patient -- With Peginterferon And Ribavirin? -- Mitchell L. Shiffman, MD -- Question 5: When A Patient Receiving Peginterferon and Ribavirin Therapy -- Develops Anemia Should I Prescribe Epoetin Alfa or Reduce -- the Dose of the Ribavirin? -- Mitchell L. Shiffman, MD -- Question 6: Is There Anything I Can Do to Improve the Chance That an African -- American With Chronic Hepatitis C Will Respond to Peginterferon -- and Ribavirin? -- Mitchell L. Shiffman, MD -- Question 7: Is It Safe to Treat Patients With Chronic Hepatitis C and Cirrhosis -- With Peginterferon and Ribavirin? -- Mitchell L. Shiffman, MD -- Question 8: How Often Should I Follow a Patient Who Had Chronic Hepatitis C -- After He Achieved a Sustained Virologic Response? -- Mitchell L. Shiffman, MD -- SECTION II: Viral Hepatitis B -- Question 9: Which Patients With Chronic Hepatitis B Require a Liver Biopsy? -- Wei Hou, MD and Mitchell L. Shiffman, MD -- Question 10: How Do I Decide Which Medication to Utilize in a Patient With -- Hepatitis B Virus? -- Mitchell L. Shiffman, MD -- Question 11: Can I Ever Stop Treatment in a Patient With Chronic Hepatitis B -- Receiving An Oral Antiviral Agent? -- Wei Hou, MD and Mitchell L. Shiffman, MD -- Question 12: How Do I Know When a Patient Receiving an Oral Antiviral -- Agent Has Developed Resistence and What Do I When This -- Happens? -- Mitchell L. Shiffman, MD -- Question 13: How Do I Treat a Patient Who Is Coinfected With Chronic Hepatitis B -- and C Viruses? -- Mitchell L. Shiffman, MD -- Section Iii: Liver Disease In Patients With Hiv Infection -- Question 14: How Does Having HIV Affect the Likelihood That My Patient -- With Chronic HCV Will Develop Cirrhosis? -- Kevin M. Comar, MD and Richard K. Sterling, MD, FACP, FACG -- Question 15: Which Patients With Chronic HCV and HIV Coinfection Should Be -- Treated With Peginterferon and Ribavirin? -- Kevin M. Comar, MD and Richard K. Sterling, MD, FACP, FACG -- Question 16: Is There a Simple Way to Treat a Patient Who Is Coinfected -- With Hepatitis B Virus and HIV? -- Richard K. Sterling, MD, FACP, FACG -- Question 17: What Things Could Cause My Patient With HIV to Develop Jaundice? -- Richard K. Sterling, MD, FACP, FACG -- Question: 18 Should I Stop HIV Medications in a Patient Who Has Developed -- an Elevation In Serum Liver Transaminases? -- Richard K. Sterling, MD, FACP, FACG -- Section Iv: Genetic Disorders That Cause Chronic Liver Disease -- Question 19: What Is the Best Screening Test for Genetic Hemochromatosis? -- Peter Dienhart, MD; Jayanta Choudhury, MD; and -- Anastasios A. Mihas, MD, DMSc, FACT, FACG -- Question 20: How Frequently Should I Have a Patient With Genetic Hemochromatosis -- Undergo Phlebotomy? -- Peter Dienhart, MD; Jayanta Choudhury, MD; and -- Anastasios A. Mihas, MD, FACT, FACG -- Question 21: What Is the Best Screening Test for Wilson¿s Disease? -- Opang Cheung, MD and Anastasios A. Mihas, MD, DMSc, FACS, FACG -- Question 22: What Should I Tell My Patient Who Is a Carrier for Alpha-1-Antitrypsin -- Deficiency? -- Anastasios A. Mihas, MD, DMSc, FACS, FACG -- Question 23: Do All Patients With Autoimmune Hepatitis Require Immune -- Suppressive Medications? -- R. Todd Stravitz, MD -- Question 24: My Patient With and Autoimmune Hepatitis Cannot Take Corticosteroids. -- Are There Any Other Medications I Could Use? -- R. Todd Stravitz, MD -- Question 25: Do I Need to Perform a Liver Biopsy in All Patients With Autoimmune -- Hepatitis Prior To Initiating Steroids? -- Andres Mogollon, MD and R. Todd Stravitz, MD -- Section V: Fatty Liver Disease -- Question 26: Which Patients With Fatty Liver Disease on Ultrasound Require -- a Liver Biopsy? -- Arun J. Sanyal, MD -- Question 27: An Obese Patient With Hypercholesterolemia Was Recently Started on a -- Statin and Is Now Found to Have Elevated Serum Liver Transaminases. -- Do I Need to Stop This Medication? -- Arun J. Sanyal, MD -- Question 28: What Is the Best Medication to Utilize In a Patient With Fatty Liver -- Disease and Type 2 Diabetes Mellitus? -- Arun J. Sanyal, MD -- Question 29: My Patient With Chronic Hepatitis C Also Has Evidence of Nonalcoholic -- Steatohepatitis (Nash) on His Liver Biopsy. What Can I Do to Increase -- His Chance of Responding to Peginterferon and Ribavirin Treatment? -- Arun J. Sanyal, MD -- Question 30: Can A Patient of Normal Body Weight, a Normal Serum Cholesterol -- Level, and No History of Diabetes Have Fatty Liver Disease? -- Arun J. Sanyal, MD -- Section Vi: Cholestatic Liver Diseases -- Question 31: When Should I Initiate Treatment With Ursodeoxycholic Acid and What -- Dose Should I Utilize In My Patient With Primary Biliary Cirrhosis? -- Puneet Puri, MD and Velimir A. Luketic, MD -- Question 32: What Type of Testing Does My Patient With Primary Biliary Cirrhosis -- Require? -- Velimir A. Luketic, MD -- Question 33: Is Ursodeoxycholic Acid Effective for the Treatment of Primary -- Sclerosing Cholangitis? -- B. Marie Reid, MD and Velimir A. Luketic, MD -- Question 34: Should I Be Screening My Patient With Primary Sclerosing Cholangitis -- for Cholangiocarcinoma? -- Michael Fuchs, MD, PhD, FEBG -- Question 35: Should All Patients With Suspected Sclerosing Cholangitis Undergo -- an ERCP to Confirm This Diagnosis? -- Michael Fuchs, MD, PhD, FEBG -- Question 36: My Patient With Ulcerative Colitis Recently Underwent a Total Colectomy -- for Severe Dysplasia. Does This Reduce The Risk That He Will Get -- Primary Sclerosing Cholangitis? -- Michael Fuchs, MD, PhD, FEBG -- Section Vii: Cirrhosis -- Question 37: Which Asymptomatic Patients With Cirrhosis Should Undergo -- an Upper Endoscopy To Determine If They Have Esophageal Varices? -- Nagib Toubia, MD; Adil Habib, MD; and Douglas M. Heuman, MD -- Question 38: I Just Banded Actively Bleeding Varicies in a Patient With Known -- Cirrhosis. The Patient Is Now Hemodynamically Stable. Is There -- Anything Else I Should Recommend? -- Nagib Toubia, MD; Adil Habib, MD; and Douglas M. Heuman, MD -- Question 39: Which Patients With Chronic Liver Disease Should I Screen For -- Hepatocellular Carcinoma? -- Douglas M. Heuman, MD and Adil Habib, MD -- Question 40: Should I Vaccinate My Patients With Cirrhosis for Viral Hepatitis -- A and B? -- Douglas M. Heuman, MD and Adil Habib, MD -- Question 41: A Healthy Patient Not Known to Have Chronic Liver Disease, With -- Normal Liver Chemistries and Liver Function Was Found to Have -- a 4-Centimeter Liver Mass on Ultrasound. Should I Biopsy This? -- Douglas M. Heuman, MD and Adil Habib, MD -- Question 42: I Was Asked to See a Patient With Tense Ascites. How Much Ascites -- Is Safe to Remove at Any One Time? -- Adil Habib, MD; HoChong S. Gilles, MS, FNP; -- Leslie M. Gallagher, MS, ANP; and Douglas M. Heuman, MD -- Question 43: I Have Been Increasing the Dose of Diuretics in My Patient -- With Ascites Over Several Weeks. He Still Has Ascites but Has -- Now Developed an Elevation in Serum Creatinine to 2.0 Mg/dl. -- What Should I Do? -- Douglas M. Heuman, MD and Adil Habib, MD -- Question 44: My Patient With Cryptogenic Cirrhosis Was Recently Hospitalized -- With Spontaneous Bacterial Peritonitis. How Long Should She Be -- Treated With Antibiotics? -- Paul Arnold, MD; Adil Habib, MD; and Douglas M. Heuman, MD -- Question 45: My Patient With Cirrhosis Has an Elevated Serum Ammonia -- but No Symptoms of Hepatic Encephalopathy. How Much -- Lactulose Should I Recommend? -- Paul Arnold, MD; Adil Habib, MD; and Douglas M. Heuman, MD -- Question 46: My Patient With Hepatic Encephalopathy Continues to Be Mildly -- Confused Despite Taking Lactulose Twice Daily And Having Multiple -- Episodes Of Diarrhea Daily. Should I Increase The Dose Further? -- Douglas M. Heuman, MD and Adil Habib, MD -- Section Viii: Liver Transplantation -- Question 47: My Patient With Cirrhosis Suffers From Severe Fatigue but Has Normal -- Liver Function and Has Never Had a Major Complication of Cirrhosis. -- Should I Refer This Patient For a Liver Transplant? -- Amrita Sethi, MD and R. Todd Stravitz, MD -- Question 48: What Should I Recommend for My Patient With Cirrhosis Who -- Was Recently Found To Have A New 2-Centimeter Liver Mass By -- Ultrasound Screening? -- Lawrence Chang, MD and R. Todd Stravitz, MD -- Question 49: I Have Been Asked to See a Patient Who Had a Liver Transplant -- 5 Years Ago In Another State. He Has Not Been Seen by His Liver -- Transplant Center In 2 Years. His Serum Creatinine Is 2.5 mg/dl -- but His Liver Enzymes and Liver Function Tests are Normal. He -- Does Not Want to Go Back To His Transplant Center. What Should -- I Do? -- R. Todd Stravitz, MD -- Index |
| Bibliography |
Includes bibliographical references and index |
| Subject |
Liver -- Diseases -- Handbooks, manuals, etc.
|
|
Liver Diseases.
|
| Genre/Form |
Handbooks and manuals.
|
| Author |
Shiffman, Mitchell L.
|
| LC no. |
2008005781 |
| ISBN |
9781556428159 softcover alkaline paper |
|
1556428154 softcover alkaline paper |
|
